Drug company to sell AIDS drugs at less than cost priceBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7288.692/a (Published 24 March 2001) Cite this as: BMJ 2001;322:692
- Scott Gottlieb
- New York
Bristol-Myers Squibb has raised the stakes in an effort to cut the prices of drugs to treat AIDS in Africa by announcing that it will sell two antiretroviral drugs in combination for $1 (66p) a day, just below the cost price. It is the first time that any drug manufacturer has made such a proposal.
The move came a week after rival pharmaceutical company Merck unveiled its own round of new price cuts, and it is further evidence that the drug industry is bowing to international pressure to increase supplies …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial